Avexxin

Business Services · Norway · 11-50 Employees

View Company Info for Free

Overview

Headquarters

Høgskoleringen 5, Trondheim, Sor-Trondel...

Phone Number

+47 73596107

Revenue

$7.2 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Avexxin

Avexxin was established in March 2005 as a result of several years of scientific work at Prof. Berit Johansen's laboratory at the Norwegian University of Science and Technology aiming at expanding the insight into and understanding of the biology of the inflammatory process. his has resulted in a novel therapeutic approach for the treatment of psoriasis and other inflammatory disorders. Besides psoriasis, the company currently has early development programs targeting rheumatoid arthritis and glomerulonephritis. The founders of Avexxin are the inventors from the Norwegian University of Science and Technology and Oslo University together with Leiv Eiriksson Nyskaping and Ventac Partners, an international team with extensive experience in the management of life science companies. In 2007, Sarsia Seed together with Karolinska Innovation became shareholders in the company. Mikael Oerum, CEO of Avexxin: "The funding of Avexxin allows the company to bring its lead compound against psoriasis tRead more
Avexxin's Social MediaPopular SearchesAvexxinAvexxin AsSIC Code 87,873NAICS Code 54,541Show more

Is Avexxin your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Avexxin is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Avexxin is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Avexxin.

Avexxin Tech Stack

A closer look at the technologies used by Avexxin

Top Business Services Companies

Frequently Asked Questions Regarding Avexxin

What is Avexxin's official website?
Avexxin's official website is www.avexxin.com
What is Avexxin's Revenue?
Avexxin's revenue is $7.2 Million
What is Avexxin's SIC code?
Avexxin's SIC: 87,873
What is Avexxin's NAICS code?
Avexxin's NAICS: 54,541
How many employees does Avexxin have?
Avexxin has 11-50 employees
What industry does Avexxin belong to?
Avexxin is in the industry of: Business Services, Research & Development
What technology does Avexxin use?
Some of the popular technologies that Avexxin uses are: Microsoft 365, Google Workspace, Gmail, Microsoft Exchange Online
How do I contact Avexxin?
Avexxin contact info: Phone number: +47 73596107 Website: www.avexxin.com
What does Avexxin do?

Avexxin was established in March 2005 as a result of several years of scientific work at Prof. Berit Johansen's laboratory at the Norwegian University of Science and Technology aiming at expanding the insight into and understanding of the biology of the inflammatory process. his has resulted in a novel therapeutic approach for the treatment of psor... iasis and other inflammatory disorders. Besides psoriasis, the company currently has early development programs targeting rheumatoid arthritis and glomerulonephritis. The founders of Avexxin are the inventors from the Norwegian University of Science and Technology and Oslo University together with Leiv Eiriksson Nyskaping and Ventac Partners, an international team with extensive experience in the management of life science companies. In 2007, Sarsia Seed together with Karolinska Innovation became shareholders in the company. Mikael Oerum, CEO of Avexxin: "The funding of Avexxin allows the company to bring its lead compound against psoriasis through to Proof-of-Concept in man. Based on Avexxin's advanced understanding of the biology of the inflammatory process, the company is developing a new topical treatment which we anticipate will offer symptom relief to psoriasis patients in a manner which is more rapid and safe compared to current topical products." Farzaad Abdi-Dezfuli, PhD, Partner at Sarsia Seed: "We are pleased to have been able to form an investment syndicate with Leiv Eiriksson Invest supporting Avexxin's advancement of its novel psoriasis treatment into clinical trials. We believe Avexxin offers a novel therapeutic approach to the treatment of chronic inflammatory disorders, particularly in dealing with mild-to-moderate psoriasis". For further information, please contact: Avexxin AS (www.avexxin.com) Mikael Oerum, CEO Tel: +45 40 64 00 04 e-mail: moe@avexxin.com or moerum@ventac-partners.com Sarsia Seed AS (www.sarsiaseed.com) Farzaad Abdi-Dezfuli, Partner Tel: +47 90 59 72 90 e-mail: farzaad.abdi-dezfuli@sarsiaseed.com Additional websites: Norwegian ...Read More

What are Avexxin social media links?
Avexxin Linkedin page
Is Avexxin a public company?
Avexxin is private company therefore does not currently have an official ticker symbol
See more information about Avexxin

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.